Latest Articles

Take a look at our summary of the top five winners of the 2022 Nikon Small World in Motion Video Competition, which showcases the very best videos and time-lapse photography from under the microscope.

In this roundup, we look at recent developments in diagnostics for genetic diseases and a range of cancers that could enable a more personalized approach for patients.

As the year ends, it’s time to reflect on the stories that you enjoyed the most. Here’s our roundup of this year’s most popular headlines, including new findings on how we humans age, the impact of diet on the microbiome and a revelation on the cause of multiple sclerosis (MS).

A new version of the Human Protein Atlas has been released, featuring the Human Disease Blood Atlas, a pan-cancer strategy that depicts proteome signatures for specific types of cancer. The atlas was created using next-generation proteome profiling methods, and offers enthusiasm for the future of the clinical proteomics field.

This article will explore the tumor microenvironment, touching on the different cells and factors that comprise it, how tumors take advantage of it and how it can be therapeutically targeted.

For oncology, plant-based anti-cancer drugs have proven instrumental in the fight against a disease that claims approximately 609,360 lives in the United States alone. But their demand far outweighs their supply. Can yeast help?

This article contains segments from five interviews with individuals currently working in STEM who identify as LGBTQIA+ to find out about their experiences, opinions and ideas to inspire the next generation.

From tweets to toots – the online community #SciTwitter is considering a move from Twitter to an alternative online platform. In this article, we explore how Twitter has supported science communication and outreach over recent years, the motivations for migration and ask: where are you heading, #SciTwitter?

Per- and polyfluoroalkyl substances (PFAS) have penetrated every corner of the globe. What do we know about them, why are they such a problem and do they really last “forever”? Science writer Kerry Taylor-Smith explores.

Technology Networks recently had the pleasure of speaking with Dr. Sam Barichievy, director in cell engineering at the biopharmaceutical company AstraZeneca. In this conversation, Dr. Barichievy shares her perspectives on what equality, diversity and inclusion entails, and how fostering inclusive environments can enable us to do better science.